A patient in the UK has received a new therapy for Huntington’s disease, which experts hope could slow progression of the ...
The findings suggest that beta-blockers and other drugs that help restore balance to the autonomic nervous system may have ...
Research indicates β-blockers may reduce the risk of motor diagnosis and slow symptom progression in Huntington's disease, ...
Novartis is paying $1 billion upfront for global rights to PTC Therapeutics’ midphase Huntington's disease program, helping ...
A recent $1 billion deal between PTC Therapeutics and Novartis for a Huntington’s disease treatment highlights a growing interest in this sector, suggesting a similar valuation could be achievable ...
The Wicked Witch of the West and I have something in common: We both use our fatal flaws to our advantage—for her, her green ...
The first patient has begun treatment on a global trial of a novel medication for Huntington's disease, led within the UK by ...